These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 20658994)
1. NMR spectroscopy of the neuronal tau protein: normal function and implication in Alzheimer's disease. Landrieu I; Leroy A; Smet-Nocca C; Huvent I; Amniai L; Hamdane M; Sibille N; Buée L; Wieruszeski JM; Lippens G Biochem Soc Trans; 2010 Aug; 38(4):1006-11. PubMed ID: 20658994 [TBL] [Abstract][Full Text] [Related]
2. NMR analysis of a Tau phosphorylation pattern. Landrieu I; Lacosse L; Leroy A; Wieruszeski JM; Trivelli X; Sillen A; Sibille N; Schwalbe H; Saxena K; Langer T; Lippens G J Am Chem Soc; 2006 Mar; 128(11):3575-83. PubMed ID: 16536530 [TBL] [Abstract][Full Text] [Related]
3. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Padmanabhan J; Levy M; Dickson DW; Potter H Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932 [TBL] [Abstract][Full Text] [Related]
4. High-resolution magic angle spinning NMR of the neuronal tau protein integrated in Alzheimer's-like paired helical fragments. Sillen A; Wieruszeski JM; Leroy A; Younes AB; Landrieu I; Lippens G J Am Chem Soc; 2005 Jul; 127(29):10138-9. PubMed ID: 16028903 [TBL] [Abstract][Full Text] [Related]
5. Conformational changes specific for pseudophosphorylation at serine 262 selectively impair binding of tau to microtubules. Fischer D; Mukrasch MD; Biernat J; Bibow S; Blackledge M; Griesinger C; Mandelkow E; Zweckstetter M Biochemistry; 2009 Oct; 48(42):10047-55. PubMed ID: 19769346 [TBL] [Abstract][Full Text] [Related]
6. NMR investigation of the interaction between the neuronal protein tau and the microtubules. Sillen A; Barbier P; Landrieu I; Lefebvre S; Wieruszeski JM; Leroy A; Peyrot V; Lippens G Biochemistry; 2007 Mar; 46(11):3055-64. PubMed ID: 17311412 [TBL] [Abstract][Full Text] [Related]
7. Structural impact of heparin binding to full-length Tau as studied by NMR spectroscopy. Sibille N; Sillen A; Leroy A; Wieruszeski JM; Mulloy B; Landrieu I; Lippens G Biochemistry; 2006 Oct; 45(41):12560-72. PubMed ID: 17029411 [TBL] [Abstract][Full Text] [Related]
8. Tau phosphorylation in neuronal cell function and dysfunction. Johnson GV; Stoothoff WH J Cell Sci; 2004 Nov; 117(Pt 24):5721-9. PubMed ID: 15537830 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and conformational properties of phosphopeptides related to the human tau protein. Du JT; Li YM; Ma QF; Qiang W; Zhao YF; Abe H; Kanazawa K; Qin XR; Aoyagi R; Ishizuka Y; Nemoto T; Nakanishi H Regul Pept; 2005 Aug; 130(1-2):48-56. PubMed ID: 15869817 [TBL] [Abstract][Full Text] [Related]
10. Application of synthetic phospho- and unphospho- peptides to identify phosphorylation sites in a subregion of the tau molecule, which is modified in Alzheimer's disease. Liu WK; Moore WT; Williams RT; Hall FL; Yen SH J Neurosci Res; 1993 Feb; 34(3):371-6. PubMed ID: 8455212 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylation modulates the local conformation and self-aggregation ability of a peptide from the fourth tau microtubule-binding repeat. Du JT; Yu CH; Zhou LX; Wu WH; Lei P; Li Y; Zhao YF; Nakanishi H; Li YM FEBS J; 2007 Oct; 274(19):5012-20. PubMed ID: 17725643 [TBL] [Abstract][Full Text] [Related]
12. Copper binding properties of a tau peptide associated with Alzheimer's disease studied by CD, NMR, and MALDI-TOF MS. Ma Q; Li Y; Du J; Liu H; Kanazawa K; Nemoto T; Nakanishi H; Zhao Y Peptides; 2006 Apr; 27(4):841-9. PubMed ID: 16225961 [TBL] [Abstract][Full Text] [Related]
13. The self-assembly ability of the first microtubule-binding repeat from tau and its modulation by phosphorylation. Zhou LX; Zeng ZY; Du JT; Zhao YF; Li YM Biochem Biophys Res Commun; 2006 Sep; 348(2):637-42. PubMed ID: 16889747 [TBL] [Abstract][Full Text] [Related]
14. Characterization of Alzheimer's-like paired helical filaments from the core domain of tau protein using solid-state NMR spectroscopy. Andronesi OC; von Bergen M; Biernat J; Seidel K; Griesinger C; Mandelkow E; Baldus M J Am Chem Soc; 2008 May; 130(18):5922-8. PubMed ID: 18386894 [TBL] [Abstract][Full Text] [Related]
15. The Study of Posttranslational Modifications of Tau Protein by Nuclear Magnetic Resonance Spectroscopy: Phosphorylation of Tau Protein by ERK2 Recombinant Kinase and Rat Brain Extract, and Acetylation by Recombinant Creb-Binding Protein. Qi H; Despres C; Prabakaran S; Cantrelle FX; Chambraud B; Gunawardena J; Lippens G; Smet-Nocca C; Landrieu I Methods Mol Biol; 2017; 1523():179-213. PubMed ID: 27975251 [TBL] [Abstract][Full Text] [Related]
16. p44mpk MAP kinase induces Alzheimer type alterations in tau function and in primary hippocampal neurons. Lu Q; Soria JP; Wood JG J Neurosci Res; 1993 Jul; 35(4):439-44. PubMed ID: 7689658 [TBL] [Abstract][Full Text] [Related]
17. Neighbored phosphorylation sites as PHF-tau specific markers in Alzheimer's disease. Singer D; Lehmann J; Hanisch K; Härtig W; Hoffmann R Biochem Biophys Res Commun; 2006 Aug; 346(3):819-28. PubMed ID: 16781671 [TBL] [Abstract][Full Text] [Related]
18. Structural characterization by nuclear magnetic resonance of the impact of phosphorylation in the proline-rich region of the disordered Tau protein. Sibille N; Huvent I; Fauquant C; Verdegem D; Amniai L; Leroy A; Wieruszeski JM; Lippens G; Landrieu I Proteins; 2012 Feb; 80(2):454-62. PubMed ID: 22072628 [TBL] [Abstract][Full Text] [Related]
19. Modification of tau to an Alzheimer's type protein interferes with its interaction with microtubules. González C; Farías G; Maccioni RB Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1117-27. PubMed ID: 9846894 [TBL] [Abstract][Full Text] [Related]
20. Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules. Amniai L; Barbier P; Sillen A; Wieruszeski JM; Peyrot V; Lippens G; Landrieu I FASEB J; 2009 Apr; 23(4):1146-52. PubMed ID: 19074508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]